Sodium (3R,5S,6E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate

Basic Information

View in Editor

CAS Number

143201-11-0

Molecular Formula

C26H33FNNaO5

Molecular Weight

458.55 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Fine Chemicals Specialty Chemicals UV Stabilizers

Agricultural Chemicals Pesticides Herbicides

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Melting Point

197-199°C

Boiling Point

646.3 ºC at 760 mmHg

Density

1.181

Flash Point

344.7 ºC

Solubility

H2O: ≥5mg/mL

Refractive Index

1.594

Specific Rotation

D20 +24.1° (c = 1 in ethanol)

SMILES

View in Editor

CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)[O-])O)O.[Na+]

InChI

InChI=1S/C26H34FNO5.Na/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4;/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32);/q;+1/p-1/b11-10+;/t19-,20-;/m1./s1

InChIKey

GPUADMRJQVPIAS-QCVDVZFFSA-M

LogP

3.546000000000003

Topological Polar Surface Area

102.71000000000001 Å²

Hydrogen Bond Donor/Acceptor

2 / 6

Complexity

626

Synonyms & References

English

Tox21_112244_1
NC00204
Certa
sodium (3R,5S,6E)-7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl)-3,5-dihydroxyhept-6-enoate
Q27106131
CHEBI:3559
CERIVASTATIN SODIUM [VANDF]
CS-0031250
Cerivastatinsodium
sodium (E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-bis(oxidanyl)hept-6-enoate
A808034
6-Heptanoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-(S-(R*,S*-(E)))-, sodium salt
HMS2051H13
bayw6228
6Q18G1060S
(3R,5S,6E)-7-[4-(4-Fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt
Bay-w-6228
DTXCID8026488
HY-109523
143201-11-0 (sodium)
Cerivastatin, sodium salt
J-007766
(+)-Sodium (3R,5S,6E)-7-(4-(p-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl)-3,5-dihydroxy-6-heptenoate
Lipobay
CPD000469148
Cerivastatin (sodium)
Tox21_303882
NCGC00357289-01
sodium (E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate
sodium;(E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate
cerivastatin sodium salt

MDL Number

MFCD20488047

FAQ

What is (3R,5S,6E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate (CAS: 143201-11-0)?

This compound is a complex organic molecule with a specific stereochemistry. It is used primarily in pharmaceuticals for its potential therapeutic properties. The compound has a unique structure that includes a heptenoate group, diisopropyl substituents, and a fluorophenyl group. It is not commonly encountered in everyday life and is more of a specialized chemical reagent.

What are the main uses of (3R,5S,6E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate (CAS: 143201-11-0)?

This compound is mainly used in the pharmaceutical industry for developing potential therapeutic agents. It shows promise in treating certain diseases, although its exact therapeutic applications are still under investigation. It is also used in research settings to study similar compounds and their interactions.

Is (3R,5S,6E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate (CAS: 143201-11-0) safe?

The safety of this compound depends on the context and application. In general, it is safe when handled with appropriate precautions. However, it should be used in a well-ventilated area and with protective equipment such as gloves and goggles to prevent skin and eye contact. It is not recommended for use by the general public and should only be handled by trained professionals in a controlled environment.

How should (3R,5S,6E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate (CAS: 143201-11-0) be stored?

This compound should be stored in a cool, dry place away from direct sunlight and heat sources. It should be kept in a tightly sealed container to prevent degradation. Ideal storage conditions include a temperature range of 15-25°C and a low humidity environment to ensure the compound remains stable and safe for use. Always store it in a secure, labeled container to avoid accidental contact or ingestion.